Rotational atherectomy for chronically and totally occluded coronary lesions: A propensity score-matched outcomes

Tien-Chien Tsai1, Wei-Jung Lo1, Wei-Jhong Chen1

  • 1Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.

Insights

Rotational atherectomy (RA) is effective for treating chronic total occlusion (CTO) lesions that are difficult to cross or dilate. This study found RA for CTO lesions has similar safety and outcomes to non-CTO lesions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Chronic total occlusion (CTO) lesions pose challenges in revascularization despite technological advancements.
  • Rotational atherectomy (RA) is often required for CTO lesions that are uncrossable or undilatable with conventional devices.

Purpose of the Study:

  • To evaluate the safety and efficacy of rotational atherectomy (RA) in treating chronic total occlusion (CTO) lesions.
  • To compare procedural outcomes and clinical events between patients undergoing RA for CTO versus non-CTO lesions.

Main Methods:

  • Retrospective analysis of consecutive patients undergoing coronary RA from a catheterization laboratory database.
  • Propensity score matching was used to compare patients with CTO lesions (CTO group) undergoing RA with a control group (non-CTO group).

Main Results:

  • 44 patients underwent RA for CTO lesions, compared to 37 propensity score-matched controls (non-CTO group).
  • No significant differences were observed in acute procedural outcomes, contrast-induced nephropathy (CIN), or major adverse cardiovascular events (MACE) up to 1 year between the CTO and non-CTO groups.
  • Patients in the CTO group had a higher incidence of diabetes and increased use of smaller burr sizes (1.25 mm).

Conclusions:

  • Rotational atherectomy (RA) is a safe and effective strategy for revascularizing chronic total occlusion (CTO) lesions.
  • RA for CTO lesions demonstrates comparable procedural safety and clinical outcomes to non-CTO lesions when analyzed with propensity score matching.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22